Dear Colleagues,
On a global scale, the pharmaceutical market is expected to grow in the years to come regardless of a recent slowdown in key markets across the globe. The increase is exacerbated by the growing and ageing population in key markets. Aside from this, increasing access to Pharmaceuticals to poor and middle-class families due to increases in disposable income also drives the industry’s growth. Pharma companies focusing on Rare and speciality medicines is another aspect leading the growth. Innovations attracting investments even from non-pharma companies are also sustaining the growth in the pharmaceutical industry.
The pharmaceutical industry is one of the major players in the healthcare sector. Payers want to provide access and fund innovative treatments to improve patient care but governments across Europe are struggling to balance the desire to provide timely access to innovative medicines with the need to contain healthcare spending due to the increasing pressure between the demands of the EU, national governments and regional authorities.
As healthcare budgets are continuously rising in Europe, governments implement a wide variety of policies to control them with the help of different public regulatory bodies that are involved in pharmaceutical coverage decisions across Europe. International collaboration among HTA and regulatory bodies can promote knowledge exchange, as do the actions payers take in an effort to reduce costs while maintaining quality care.
The upcoming 2023 Market Access, Pricing and Reimbursement Global Congress Europe will present a dynamic approach to key trends and insights on market access, health
technology assessment, real-world data, patient access, pricing and reimbursement on the current European landscape.
This year, we are putting together an agenda that addresses “Trends and Strategies to Achieve Optimum Patient Access to Healthcare”. We are gathering together high calibre expert speakers to participate and share their knowledge and expertise through Keynote Presentations and Panel discussions, addressing all aspects of the industry.
We look forward to welcoming you to the MAPR 2023 congress!
Sincerely yours,
Jocelyn is Conference Director at Paradigm Global Events (PGE). She has over 15+ years experience in organizing pharma-industry conferences and has been at the helm of every PGE conference since 2013. Jocelyn is based in London, UK.
Why you should attend:
You Will Meet:
WHO SHOULD ATTEND:
Network with members of boards, VP’s, Directors, Heads/Chiefs and Senior Managers of leading biopharmaceutical and biotech companies, government, CRO and solution providers involved in:
2023 Speakers
Content Rich Program Agenda! Featuring Keynote Presentations, Stream Sessions, Panel, and Round Table Discussions.
Santoke Naal, Director Market Access, IGES U.K. Pharma Ltd
Claudia Neuber, Head, Global Pricing Oncology, Global Market Access & Pricing, AstraZeneca
This year’s 9th Market Access, Pricing & Reimbursement Global Congress 2023 Europe, will be co-located with the 2nd Real-World Evidence World Congress 2023 Europe.
Sponsors & Exhibitors will have the opportunity to Network with Attendees from both Events.
No Spam - You will only receive relevant information on Patient Centricity & Collaboration, and event updates
what people say
Book Your Place Now!
Take Advantage of the Super Early Bird Discount. Group Discounts Also Available.
